What we do Vivanza Biosciences Ltd develops and commercializes novel and generic pharmaceutical products focused on safe and accessible medicines, operating primarily in India with global aspirations. |
Founded in 1,982 |
Market share A niche player in pharmaceutical formulations, expanding capacity for greater market presence, with facilities for both glass and plastic container products. |
Problem solved Improves patient access to better and safer pharmaceutical medicines through generic and novel products. |
Top clients or who we serve Serves healthcare providers, pharmacies, and patients in the pharmaceutical sector (B2B and B2C). |
Key management - |
Our journey and innovations Founded as Ivee Injectaa in 1982, renamed Vivanza Biosciences in 2015; expanded capacity from 1.8 to 5.4 million units; acquired Vivanza Lifesciences Pvt Ltd in 2016. |
Where we operate Based in India with plans and initiatives to expand globally. |
Top products or what we offer Pharmaceutical formulations including injectable solutions, supplied in both glass and plastic containers. |
Top brands - |
Raw materials needed Active pharmaceutical ingredients for injectable formulations. |
Raw materials supplier - |
Recurring vs cyclical contribution Revenue impacted by cyclical market conditions; experiencing some fluctuations in recent years. |
Our industry position Mid-size pharma firm with growing capacity and efforts to strengthen market position. |
Financial highlights FY 2025 revenue Rs. 7.42 crore; net loss Rs. 0.67 crore; company focusing on turnaround and growth. |
Geographical revenue split Revenue mostly generated within India. |
Order book - |
Whats driving growth Expansion of manufacturing capacity and diversification into global markets driving growth potential. |
Our future plans Capacity expansion, increasing global footprint, enhancing product portfolio for wider reach. |
Our green promise - |
Our people and values Committed workforce focused on quality and compliance, fostering ethical pharmaceutical manufacturing. |
Key challenges ahead Facing market competition, financial turnaround pressures, and scaling regulatory compliance for global markets. |
Interesting facts One of few companies with combined glass and plastic pharmaceutical container facility in India. |
Risks and strategy Mitigates market volatility and regulatory risks through diversification and quality focus. |
